depletion of T, B or neoplastic cells from PC collected by apheresis. To evaluate a new 'two step' method for purging T, B and neoplastic cells from hematopoietic progenitor cells (PC), PCs were collected by apheresis and some suspensions were deliberately contaminated with 2-5% breast Materials and methods cancer cells. PCs were first processed through CellPro columns for positive selection of cells that express CD34. After this first step, the mean CD34 + cell recovery was PC collection and processing 68 ؎ 12%, and CD34
PC, T, B and neoplastic cell evaluation
Before processing, a mean of 1.1 Ϯ 0.8% of nucleated cells were CD34 + , and average CAFC frequency was 1:11 270 PE-or FITC-labeled anti-CD3, CD4, CD8, CD19, CD20, nucleated cells. As shown in Table 1 , after the positive CD33, CD34 and CD38 monoclonal antibodies manufacselection step about 35% of CD34 + cells were lost, and tured by Becton Dickinson (Mountain View, CA, USA), after the second step the final CD34 + cell recovery was PharMingen (San Diego, CA, USA) and Immunotech 50 Ϯ 7%. After 'two step' T and B cell removal, CAFC (Marseille, France) were used to enumerate T, B and PC.
recovery was 48 Ϯ 9% (n = 5); after 'two step' neoplastic A total of 100-500 × 10 3 cells were incubated at 22°C for cell removal, CAFC recovery was 53 Ϯ 11% (n = 5). 30 min in PBS-1% BSA with monoclonal antibodies. By
Recovery of immature progenitors was also supported by means of flow cytometry (FACScan; Becton Dickinson), the observation that the percentage of CD34 + cells which the percentage of stained cells was determined as compared were CD33 and CD38 negative (lineage−) was not signifito PE-or FITC-conjugated mouse isotypic control. A porcantly reduced after the purging procedure (7-18% before tion of each sample was incubated with the appropriate isoand 12-20% after the 'two step' purging procedure). The type control antibodies to establish the background level of first step allowed 1.9-2.1 log depletion of T, B and neoplasnon-specific staining, and positivity was defined as being tic cells, and after the final negative depletion T and B cell greater than non-specific background staining. Cell viability removal was 4.7 Ϯ 0.4 log and neoplastic cell purging was was evaluated by staining cells with ethidium bromide and 4.4 Ϯ 0.3 log (significantly increased level of purging comacridine orange. Dead cells were gated out based on orange pared to the 'first step' only, P Ͻ 0.001). In unmanipulated fluorescence. For neoplastic cell evaluation, pre-and postsamples from breast cancer patients, as expected, the freprocessing cytospin slides of 2.5 × 10 6 cells were stained quency of contaminating breast cancer cells was low (1-with a commercially available APAAP 6 based kit for cyto-50 cells out of 10 × 10 6 WBC evaluated before depletion keratin-positive breast cancer cell detection (Micromet, and absence of breast cancer cells in 10 × 10 6 WBC evaluPlanegg, Germany). At least 1 × 10 7 cells per sample were ated after two step depletion); given the sensitivity of our analyzed by microscopy for enumeration of breast cancer procedure, in these studies efficiency of neoplastic cell cells. Using breast cancer lines in limiting dilution assays, removal was reported as Ͼ4 log (Table 2 ). Since anti-CD3 the sensitivity of our immunohistochemistry procedure for and anti-CD19 tetramers could partially block the sites for breast cancer cell enumeration was found to be of one cyto-CD3 and CD19 staining, on three occasions T and B cell keratin-positive cell out of 500 × 10 3 evaluated cells. removal was further confirmed to be in the range of The frequency of cobblestone area-forming cells (CAFC, 4.7 Ϯ 0.4 by enumeration of CD4 + , CD8 + and CD20 + cells. or long-term culture-initiating cells, LTC-IC) was evaluted Figure 1 shows a representative flow cytometric analysis before and after cell processing. We followed the LDA of cells before and after processing. To assess whether breassay recently described by Pettengell et al 7 with few modiast cancer cells used in this study were expressing the CD34 fications. Briefly, a layer of genetically engineered M2-antigen as previously reported for some patient samples,
8
10B4 murine stromal cells was generated in 96-well plates CG5 and CAMA-1 cells were evaluated by flow cytometry in the presence of Long Term Myelocult Medium (Stemand found to be CD34 negative. Cell Technologies). The layer was irradiated (80 Gy), a minimum of 0.5 × 10 3 and maximum of 30 × 10 3 nucleated cells/ml were seeded in five different dilutions in 10 repliDiscussion cate wells each. Cultures were fed weekly with Myelocult medium. At the end of 5 weeks culture, wells were evalu-A number of procedures including T cell depletion, neoated as positive or negative for the presence of cobblestone plastic cell purging and ex vivo PC expansion are currently areas, defined as clusters of small, tightly packed cells that under evaluation to improve the clinical outcome of PC were nonrefractory when viewed under a phase contrast transplantation. In the present study we have investigated microscope and originated from a CAFC. At week 5, wells a novel 'two step' procedure which can be utilized for both with cobblestone areas of greater than 15 cells or three sepallogeneic and autologous PC transplant. In our system, the arate foci of more than five cells were scored as positive.
main beneficial effect of the CD34 + cell enrichment step is to debulk the graft, and 4.5 log depletion of target cells is obtained by the second negative depletion procedure. By Data analysis means of flow cytometry and long-term cultures, we have Statistical comparisons were performed by Primer estimated that about 50% of PC were recovered after the (McGraw Hill, New York, NY, USA) and StatWiew 'two step' purging. Moreover, the procedure did not selec-(Abacus Concepts, Berkeley, CA, USA) software using the tively remove more immature progenitors such as non-parametric analyses of Mann-Whitney, Wilcoxon and CD34 + lineage− cells and CAFC. These assays are currently Kruskal-Wallis. Values of P lower than 0.05 were conthought to be among the best surrogate for early hematosidered as statistically significant. poietic progenitor enumeration. 7, 9, 10 Very high doses of T cell-depleted PC collected from BM and peripheral blood of HLA-mismatched related Results donors have been recently used with success to engraft patients who lacked an HLA-matched donor. 1,11 Since 3 to 4 log depletion of donor T cells is needed to avoid severe On 19 occasions, 2.1 Ϯ 3.3 × 10 9 cells were processed through CellPro (first step) and StemSep (second step).
GVHD in these patients, the new 'two step' procedure is a 
CD34
+ cell recovery and cell purging after the first (positive selection) and the second (negative selection) procedure for immunoaffinity removal of T, B and breast cancer cells. In the first step, hematopoietic progenitor cells (PC) collected from cancer patients by apheresis were processed through CellPro columns for positive selection of cells which express CD34. In the second step, PC were further processed by the StemSep 'negative depletion' device for immunodepletion of T and B cells targeted with anti-CD3 and anti-CD19 antibodies or of breast cancer cells targeted with the 5E11 antibody. In the study of breast cancer cell removal the start cell suspensions were mixed with 2-5% breast cancer cells from the CG5 and CAMA-1 cell lines. Mean 1100 ± 150 11 ± 3 1.1 ± 1.5 68 ± 6 6 6±5 0.1 ± 0.1 52 ± 4 7 1±6 0.0 Ͼ4 ± 1 s.d.
Breast cancer cell removal in four apheresis samples from breast cancer patients. Cells underwent positive CD34 + cell selection (first step) and negative depletion of breast cancer cells (second step). An aliquot of Ͻ5% of the apheresis product was processed.
good alternative to the more cumbersome and less effective viruses like EBV, and could be used in the future for selective removal of CD4
, natural killer or dendritic soybean agglutination plus E-rosetting method used in these studies. Moreover, the new method has the advantage cells, ie cell subsets that might play a pivotal role in the onset of GVHD. However, it must be remembered that T of the selective removal of B cells, which can carry harmful cells exert a graft-versus-leukemia effect, and that extensive selection of CD34 + cells is clearly not indicated, but a second negative selection step would ensure removal of T cell depletion has led in the past to graft failure in BM transplant recipients. Clinical studies are now warranted to neoplastic cells. Phase I-II trials based upon this new technology will evaluate the clinical benefit of extensive neoevaluate the engraftment potential and the residual anti-leukemia effect of 4.5 log T cell-depleted PC. plastic cell removal. For the autologous PC transplantation setting, the new 'two step' approach is associated with a purging efficiency significantly superior to methods described in the past, [12] [13] [14] [15] Acknowledgements and can also be used for removal of clonal CD34 licular lymphoma patients. 16 Regarding the 5E11 mono- vious studies 17 it was found to be the most suitable for breast cancer cell removal among a panel of monoclonal antibodies reacting with epithelial antigens expressed on References breast cancer cells and absent on hematopoietic cells. The 5E11 hybridoma was raised from a fusion of Sp2 cells and 
